FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35910711000001107: Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110959501000001118 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110959601000001119 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.scalp ontology form and route true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Plays role Antifungal therapeutic role true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Is a Salicylic acid + Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Is a Product containing betamethasone and salicylic acid false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (PI) (Waymade Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Dowelhurst Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Sigma Pharmaceuticals Plc) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Mawdsley-Brooks & Company Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
Diprosalic scalp application (Necessity Supplies Ltd) Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start